Morgan Stanley’s Evotec EVO Stock Holding History
Bought
Maintained
Sold
Other funds holding EVO
DA
AA
OMC
FC
SCA
Morgan Stanley's EVO Position: Q2 2026 in Review
Morgan Stanley reduced its Evotec (EVO) stake by 21% in Q2 2026, selling an estimated $156K and leaving 205,763 shares worth $576K. The position accounts for ﹤0.01% of the portfolio, ranked #5480.
Morgan Stanley first reported a position in EVO in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.62M in Q2 2025. 34 funds tracked by Wall St. Rank hold EVO as of Q2 2026.
- Morgan Stanley held 205,763 shares of Evotec worth $576K as of Q2 2026.
- Morgan Stanley sold 53,981 Evotec shares in Q2 2026, an estimated $156K.
- Evotec made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5480 holding.
- Morgan Stanley first reported a position in Evotec in Q4 2021 and has held it in 19 quarters since.
- Morgan Stanley's Evotec position peaked at $1.62M in Q2 2025.
- 34 funds tracked by Wall St. Rank held Evotec as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.